Menu
Recruiting NCT07446790

Scan Time and Prosthetic Complications of Intraoral Scanning Versus Intraoral Photogrammetry for Full-Arch Titanium Framework With Zirconia Overlay Implant Screw-Retained Prostheses

No phase Interventional Scan Time

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Intraoral photogrammetry (IOP), Intraoral scanner (IOS).
Who it may be relevant to
Registry conditions: Scan Time. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Scan Time and Prosthetic Complications of Intraoral Scanning Versus Intraoral Photogrammetry for Full-Arch Titanium Framework With Zirconia Overlay Implant Screw-Retained Prostheses: A Randomized Clinical Trial

Overview

This study aims to evaluate the effect of intra-oral scanning and intra-oral photogrammetry on scan time and prosthetic complications in patients receiving full-arch titanium framework with zirconium overlay implant screw-retained prostheses. Participants will: Receive a full arch implant prosthesis and scan time will be recorded. Prosthetic complications (e.g., screw loosening, framework fracture, zirconia chipping) will be recorded at 3 and 6-month follow-up period post-delivery and we will manage complications at the time of prosthetic complication occurrence.

Interventions

  • Device Intraoral photogrammetry (IOP)
    IOP will be used in the study to take a digital impression for the implants. The scanner will be used to record the soft tissue anatomy and trans-mucosal abutments. 3D Scan bodies will be fitted on the trans-mucosal abutments that are screwed on the implants to capture their position and scanning will be done. A scan of the soft tissue and scan bodies will finally be conducted.
  • Device Intraoral scanner (IOS)
    Intra-oral scanner will be used in the study to take a digital impression for the implants. 3D printed generic Scan bodies with unified shape and length replacing the traditional transfer copings will be press fitted on the trans-mucosal abutments and pickup cylinders that are screwed on the implants to capture their position and intra-oral scanning will be done.

Primary outcome measures

  • Scan time [Time frame: At week 1 during the clinical visit of scanning the arch and bite registration.]
Secondary outcome measures (1)
  • Prosthetic complications [Time frame: At 3, 6 months of delivery of final prosthesis.]

Eligibility criteria

Inclusion criteria

  • Patients requiring maxillary and/or mandibular full arch screw-retained implant-supported prosthesis.
  • Number of implants placed per arch ranging from 4-6 implants per arch.
  • Completely edentulous patients with sufficient inter-arch space to receive fixed prosthesis (Crown height space 9-15 mm per arch).
  • Adequate zone of keratinized mucosa (> 2mm width).
  • Both genders.
  • Acceptable oral hygiene.
  • Cooperative patients.
  • Controlled systemic diseases (Diabetes, hypertension).

Exclusion criteria

  • Completely edentulous patients with insufficient inter-arch space to receive fixed prosthesis (Crown height space lesser than 9mm per arch).
  • Completely edentulous patients with in-adequate zone of keratinized mucosa (< 2mm).
  • Un cooperative patients.
  • Poor oral hygiene.
  • Uncontrolled systemic diseases (Diabetes, hypertension).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Cairo

Identifiers

NCT: NCT07446790 · 30725

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗